
|Articles|June 1, 2001
Surface-treated prostheses receive FDA approval
Minneapolis-American Medical Systems has received FDA approval for InhibiZone, an antibiotic surface treatment used on its AMS 700 series penile prostheses. The treatment is impregnated through a patented process into the tissue-contacting surfaces of the prostheses. In laboratory testing, the device elutes the drugs from the surface when exposed to a warm, moist environment, providing antibiotic action both on the surface and in a zone surrounding the treated device, according to the company.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
5





